XML 37 R7.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF CASH FLOWS
¥ in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2020
CNY (¥)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
CNY (¥)
Dec. 31, 2018
CNY (¥)
Cash flows from operating activities:        
Net loss ¥ (1,343,630) $ (205,920) ¥ (729,382) ¥ (199,371)
Depreciation of property and equipment 127,836 19,592 87,887 66,903
Amortization of Intangible Assets 66,597 10,206 155,002 153,258
Amortization of right-of-use assets 28,952 4,437 79,683  
Allowance for credit losses 829,652 127,150 185,130 2,568
Change in fair value of contingent consideration (5,451) (835) 344 (5,242)
Foreign exchange (losses)/gains (15,682) (2,403) (82) 14,279
Loss from long-term investments 49,502 7,587    
Loss from disposal of property and equipment and intangible assets 3,790 581 1,501 1,368
Loss from impairment of Intangible asset 31,876 4,885 32,014  
Share-based compensation expenses 20,464 3,136 61,736 68,738
Change in deferred tax liabilities (8,797) (1,348) (2,727) (2,362)
Remeasurement of equity investments 9,021 1,383 (18,356) (12,581)
Change in fair value of investments (60,630) (9,292) (17,977) (8,153)
Gain from disposal of equity investment     (24) (1,850)
Share of results of equity investees (797) (122) (2,223)  
Changes in operating assets and liabilities:        
Accounts receivable 208,175 31,904 (55,043) (60,584)
Short-term and long-term amounts due from related parties 9,553 1,464 49,815 14,810
Prepayments and other current assets 447,332 68,557 160,205 (1,867)
Accrued interests of yield enhancement products       10,580
Other non-current assets (45,233) (6,932) 103 (25,606)
Operating lease liabilities, current and non-current (24,983) (3,829) (73,315)  
Accounts and notes payable (492,659) (75,503) (36,253) 553,445
Amounts due to related parties (8,721) (1,337) (47,404) (9,765)
Salary and welfare payable (64,936) (9,952) 5,860 (83,274)
Taxes payable (6,203) (951) (11,383) (8,748)
Advances from customers (905,118) (138,715) 44,498 (152,335)
Accrued expenses and other liabilities (163,025) (24,986) 15,234 (34,719)
Accrued interests of amounts due to the individual investors of yield enhancement products       (6,559)
Non-current liabilities     (5,304) (4,844)
Net cash provided by/(used in) operating activities (1,313,115) (201,243) (120,461) 268,089
Cash flows from investing activities:        
Purchase of short-term investments (1,460,051) (223,763) (2,041,280) (1,858,032)
Proceeds from maturity of short-term investments 1,445,422 221,521 1,614,098 4,067,804
Proceeds from maturity of yield enhancement products       172,458
(Increase)/decrease in loan receivable 241,003 36,935 (16,584) (1,326,160)
Purchase of property and equipment and intangible assets (28,330) (4,342) (122,479) (119,442)
Cash paid for long-term investments     (547,205) (874,120)
Proceeds from maturity of long-term investments 904,755 138,660 568,532 91,030
Cash received from disposal of equity investment 56,574 8,670   3,114
Cash paid for acquisition, net of cash received (310) (48) (33,216) (2,660)
Net cash provided by/(used in) investing activities 1,159,063 177,633 (578,134) 153,992
Cash flows from financing activities:        
Cash paid for repurchase of ordinary shares (308) (47) (13,547) (139,070)
Proceeds from issuance of ordinary shares upon exercise of options 58 9 109 4,585
Contingent consideration paid for business acquisitions (14,019) (2,149) (13,921) (6,800)
Repurchase of redeemable noncontrolling interests (10,000) (1,533) (37,733) (30,000)
Acquisition of noncontrolling interests of subsidiaries     (3,415)  
Cash contribution from noncontrolling interests     1,500 2,117
Proceeds from yield enhancement products       (171,412)
Repayment of borrowings and discounted notes (918,532) (140,770) (281,354) (390)
Proceeds from borrowings and discounted notes 733,255 112,376 833,471 195,758
Net cash (used in)/provided by financing activities (209,546) (32,114) 485,110 (145,212)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 5,187 795 4,974 (21,754)
Net increase/(decrease) in cash, cash equivalents and restricted cash (358,411) (54,929) (208,511) 255,115
Cash, cash equivalents and restricted cash at the beginning of year 622,515 95,405 831,026 575,911
Cash, cash equivalents and restricted cash at the end of year 264,104 40,476 622,515 831,026
Supplemental disclosure of cash flow information        
Income tax paid 3,515 539 2,286 3,740
Supplemental disclosure of non-cash investing and financing activities        
Accrual related to purchase of property and equipment 5,632 863 12,473 5,202
Receivables related to exercise of stock options (45) (7) (55) (23)
Accrual related to purchase business acquisitions ¥ 10,750 $ 1,647 ¥ 30,530 ¥ 36,456